ID: MRFR/HC/3098-CRR | October, 2017 | Region: Global | 85 pages | Cooked Research Reports
Monoclonal is a class of antibodies, which are derived from the identical offspring of a hybridomas. These antibodies can be grown indefinitely and are very specific for a particular location in the body derived from a single clone. Monoclonal antibodies recognize and bind to antigens to discriminate between specific epitopes, which provides protection against disease organisms. The specificity of MABs allow its binding to cancerous cells, which then seek outs to destroy the cancer cells. Monoclonal antibody custom service offers the selection of the developed rat and mouse hybridomas for the production of custom monoclonal antibodies from synthesized peptide or recombinant protein antigens. These services provides a comprehensive services for antibody cloning, expression, engineering, and purification in addition to custom antibody development for multiple pharmaceutical and biotechnological companies. The prices of custom antibody service depends on various factors such as type, titer and functional specifications of antibody produced. The pricing for custom monoclonal antibodies ranges from USD 3,500 to USD 11,500 per order.
Notably, increasing investment in the research & development is the key factor driving the monoclonal antibody custom service market. As per the report published in R&D magazine in 2016, total R&D expenditure was around USD 2.06 trillion. From the past few years, the China’s R&D investment is growing 10% per year and Asia accounts for over 42% of total R&D investments across the globe. Other factors such as, increasing prevalence of chronic diseases, infections, and rising occurrence of immunological diseases are also fueling the market growth. Rising demand for personalized medicine is also a vital factor responsible for the increasing development of therapeutic antibodies. However, high cost of the monoclonal antibody services may hinder the growth of the market over the forecast period. Monoclonal antibody has different applications, and one of its application, purification of antibody culture, costs around USD 1000.
It is estimated that monoclonal antibody custom service market is expected to grow at a CAGR of 10.84% during the forecast period 2017-2023.
Figure: Global monoclonal antibody custom service market, by type market share, 2016 (%)
Sources: Annual reports, Press release, White paper, Company presentation
The global monoclonal antibody custom service market is segmented on the basis of type, application, and end-users.
On the basis of type, the market is segmented into rat custom monoclonal antibody, rabbit custom monoclonal antibody, and others.
On the basis of application, the market is classified into diagnostic application, therapeutic application, and protein purification. The diagnostic application is sub-segmented into biochemical analysis, and diagnostic imaging. The biochemical analysis is further segmented into pregnancy, cancer, hormonal disorder, and infectious diseases. The diagnostic imaging is further segmented into cardiovascular diseases, cancer, and bacterial infections. The therapeutic application is further segmented into MAb as therapeutic agents, MAb as targeting agents.
On the basis of end -users, the market is segmented into hospital, research & academic laboratories, pharmaceutical & biotechnology companies, and others.
The Americas dominates the monoclonal antibody custom service market owing to the presence of patient population, well-developed technology, high healthcare expenditure and the presence of the leading players. According to the National Cancer Institute in 2016, 1.6 million new cancer cases were diagnosed in the US.
Europe holds the second position in the monoclonal antibody custom service market. It is expected that the support provided by the government bodies for research & development drives the market in European region.
Asia-Pacific region is projected to be the fastest growing region during the forecast period. The high growth rate is due to increasing risk of infectious diseases in this region.
The Middle East and Africa holds the least share in the market owing to the presence of poor and slow developing countries, especially, in African region.
Some of key the players in the market are Thermo Fisher Scientific, GenScript, Abnova Corporation, Creative-Biolabs, Abcam plc, ProMab Biotechnologies Inc, Envigo, and others.
Sources: Annual reports, Press release, White paper, and Company presentation